von Mehren M, Randall RL, Benjamin RS, et al (2018) Soft tissue sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw16:536–563
Sbaraglia M, Bellan E, Dei Tos AP (2021) The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica 113:70–84
Demetri GD, Baker LH, Beech D et al (2005) Soft tissue sarcoma clinical practice guidelines in oncology. J Natl Compr Canc Netw 3:158–194
PubMed PubMed Central Google Scholar
Szurian K, Kashofer K, Liegl-Atzwanger B (2017) Role of next-generation sequencing as a diagnostic tool for the evaluation of bone and soft-tissue tumors. Pathobiology 84:323–338
Article CAS PubMed Google Scholar
de Alava E (2017) Ewing sarcoma, an update on molecular pathology with therapeutic implications. Surg Pathol Clin 10:575–585
Arnold MA, Barr FG (2017) Molecular diagnostics in the management of rhabdomyosarcoma. Expert Rev Mol Diagn 17:189–194
Article CAS PubMed PubMed Central Google Scholar
ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25:iii102–12
Tian Z, Yao W (2023) Chemotherapeutic drugs for soft tissue sarcomas: a review. Front Pharmacol 14:1199292
Article CAS PubMed PubMed Central Google Scholar
Kyriazoglou A, Gkaralea LE, Kotsantis I et al (2022) Tyrosine kinase inhibitors in sarcoma treatment. Oncol Lett 23:183
Article CAS PubMed PubMed Central Google Scholar
Tang F, Tie Y, Wei YQ et al (2021) Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Biochim Biophys Acta Rev Cancer 1876:188606
Article CAS PubMed Google Scholar
Nakano K, Takahashi S (2020) Precision medicine in soft tissue sarcoma treatment. Cancers (Basel) 12:221
Article CAS PubMed Google Scholar
Gounder MM, Agaram NP, Trabucco SE et al (2022) Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma. Nat Commun 13:3406
Article CAS PubMed PubMed Central Google Scholar
Chen S, Zhou Y, Chen Y et al (2018) fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884–i890
Article PubMed PubMed Central Google Scholar
Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754–1760
Article CAS PubMed PubMed Central Google Scholar
Lai Z, Markovets A, Ahdesmaki M et al (2016) VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res 44:e108
Article PubMed PubMed Central Google Scholar
Li Q, Wang K (2017) InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet 100:267–280
Article CAS PubMed PubMed Central Google Scholar
Talevich E, Shain AH, Botton T et al (2016) CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol 12:e1004873
Article PubMed PubMed Central Google Scholar
Newman AM, Bratman SV, Stehr H et al (2014) FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics 30:3390–3393
Article CAS PubMed PubMed Central Google Scholar
FDA Recognition of Public Human Genetic Variant Databases. (Official FDA website, 2024) or MSK's Precision Oncology Knowledge Base
Drilon A, Laetsch TW, Kummar S et al (2018) Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med 378:731–739
Article CAS PubMed PubMed Central Google Scholar
Hasegawa N, Hayashi T, Niizuma H et al (2024) Detection of novel tyrosine kinase fusion genes as potential therapeutic targets in bone and soft tissue sarcomas using DNA/RNA-based clinical sequencing. Clin Orthop Relat Res 482(3):549–563
Jin G, Wang C, Jia D et al (2021) Next generation sequencing reveals pathogenic and actionable genetic alterations of soft tissue sarcoma in Chinese patients: a single center experience. Technol Cancer Res Treat 20:15330338211068964
Article CAS PubMed PubMed Central Google Scholar
Gan M, Zhang C, Qiu L et al (2022) Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients. Cancer Med 11:4070–4078
Article CAS PubMed PubMed Central Google Scholar
Zhang Q, Yang Y, You X et al (2023) Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas. Front Oncol 13:1173275
Article CAS PubMed PubMed Central Google Scholar
Sharpless NE (2005) INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res 576:22–38
Article CAS PubMed Google Scholar
Nakano K, Takahashi S (2020) Precision medicine in soft tissue sarcoma treatment. Cancers (Basel) 12:221
Article CAS PubMed Google Scholar
Delattre O, Zucman J, Melot T et al (1994) The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294–299
Article CAS PubMed Google Scholar
Riggi N, Cironi L, Suvà ML, et al (2007) Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol 213:4–20
Riggi N, Cironi L, Provero P et al (2005) Development of Ewing’s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65:11459–11468
Article CAS PubMed Google Scholar
Riggi N, Suvà ML, Suvà D et al (2008) EWS-FLI-1 expression triggers a Ewing’s sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res 68:2176–2185
Article CAS PubMed Google Scholar
Ladanyi M, Antonescu CR, Leung DH et al (2002) Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 62:135–140
McBride MJ, Pulice JL, Beird HC et al (2018) The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma. Cancer Cell 33:1128-1141.e7
Article CAS PubMed PubMed Central Google Scholar
Nielsen TO, Poulin NM, Ladanyi M (2015) Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy. Cancer Discov 5:124–134
Article CAS PubMed PubMed Central Google Scholar
Koboldt DC (2020) Best practices for variant calling in clinical sequencing. Genome Med 12(1):91
Comments (0)